Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
162.4 USD | -0.12% | -3.34% | +4.66% |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.66% | 288B | |
+33.29% | 704B | |
+28.05% | 577B | |
-4.45% | 348B | |
+18.38% | 327B | |
+14.57% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.66% | 147B | |
-9.19% | 145B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Says Potential Treatment for Giant Cell Arteritis Met Endpoints in Phase 3 Study